ALEX DAEISADEGHI: Open Payments
NPI 1083259725 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 10 payments from 8 companies in 2025. Trend: 2023 $583 · 2024 $48 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Electromed, Inc. | 1 | $15 |
Products named: AIRSUPRA, MOUNJARO, KISUNLA, JARDIANCE, ZORYVE, GEMTESA, AREXVY, BREZTRI.
Industry payments across CA — which companies pay providers there.
